These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11184497)

  • 21. Guidance for commissioners on the cost effectiveness of smoking cessation interventions.
    Parrott S; Godfrey C; Raw M; West R; McNeill A
    Thorax; 1998 Dec; 53 Suppl 5 Pt 2(Suppl 5):S1-38. PubMed ID: 10226676
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reach and effectiveness of mailed nicotine replacement therapy for smokers: 6-month outcomes in a naturalistic exploratory study.
    Zawertailo L; Dragonetti R; Bondy SJ; Victor JC; Selby P
    Tob Control; 2013 May; 22(3):e4. PubMed ID: 22496352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
    Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
    JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobacco-related research funding at the National Cancer Institute: Portfolio analysis, fiscal year 2003.
    Ponder P; Jefferson AM; Backinger C; Grana R
    Nicotine Tob Res; 2007 Oct; 9(10):1053-7. PubMed ID: 17943621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of tobacco control expenditures on smoking initiation and cessation.
    Marti J
    Health Econ; 2014 Dec; 23(12):1397-410. PubMed ID: 24038447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successes and new emerging challenges in tobacco control: addressing the vector.
    Mackay JM; Bettcher DW; Minhas R; Schotte K
    Tob Control; 2012 Mar; 21(2):77-9. PubMed ID: 22345225
    [No Abstract]   [Full Text] [Related]  

  • 28. Funding. Share & share alike.
    Shepherd S
    Health Serv J; 2007 Jun; 117(6062):suppl 12-3. PubMed ID: 17844886
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016.
    Max W; Sung HY; Lightwood J
    Tob Control; 2013 May; 22(e1):e10-5. PubMed ID: 22253003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the health and economic consequences of smoking interactive model.
    Orme ME; Hogue SL; Kennedy LM; Paine AC; Godfrey C
    Tob Control; 2001 Mar; 10(1):55-61. PubMed ID: 11226362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Funding shortfalls create priority problems for NCI's ASSIST program.
    Oncology (Williston Park); 1993 Aug; 7(8):36. PubMed ID: 8398632
    [No Abstract]   [Full Text] [Related]  

  • 32. State tobacco settlement funds not being spent on vigorous tobacco control efforts.
    Givel MS; Glantz SA
    Oncology (Williston Park); 2002 Feb; 16(2):152, 155-7. PubMed ID: 11866133
    [No Abstract]   [Full Text] [Related]  

  • 33. Feasibility, cost, and cost-effectiveness of a telephone-based motivational intervention for underserved pregnant smokers.
    Parker DR; Windsor RA; Roberts MB; Hecht J; Hardy NV; Strolla LO; Lasater TM
    Nicotine Tob Res; 2007 Oct; 9(10):1043-51. PubMed ID: 17943620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Between anti-smoking policies and tobacco farming subsidies--the case of Macedonia.
    Lazarevik V; Spasovski M; Donev D
    Eur J Public Health; 2013 Jun; 23(3):354-5. PubMed ID: 23275476
    [No Abstract]   [Full Text] [Related]  

  • 35. Tax and spend: a policy to help poor smokers.
    Marsh A
    Tob Control; 1997; 6(1):5-6. PubMed ID: 9176976
    [No Abstract]   [Full Text] [Related]  

  • 36. Helping smokers quit in secondary-care services.
    Lancet; 2013 Nov; 382(9907):1758. PubMed ID: 24290581
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking cessation.
    Gosney M
    Gerontology; 2001; 47(5):236-40. PubMed ID: 11490141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financial incentives to help pregnant women stop smoking are highly cost-effective.
    Community Pract; 2016 Jan; 89(1):7. PubMed ID: 26911089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.